Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
Page 1 of 1
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
Jon Moulton Thu Mar 10, 2011 10:38 am
Wilton SD, Fletcher S. Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents. The Application of Clinical Genetics. 2011 Mar 11;2011(4):29-44.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Eteplirsen for the treatment of duchenne muscular dystrophy
» The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
» Targeting mRNA Splicing as a Potential Treatment for Duchenne Muscular Dystrophy
» Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production
» PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment
» The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
» Targeting mRNA Splicing as a Potential Treatment for Duchenne Muscular Dystrophy
» Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production
» PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum